Glibenclamide population pharmacokinetic/pharmacodynamic modeling in South African type 2 diabetic subjects
Clinical Pharmacology: Advances and Applications · 2016
DOI: 10.2147/cpaa.s102674 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Pharmacology: Advances and Applications, 2016. Verfasst von Virendra Rambiritch und 2 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacology Department, University of KwaZulu-Natal, Durban. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pharmacology Department, University of KwaZulu-Natal, Durban.
- Department of Internal Medicine, RK Khan Regional Hospital, Chatsworth, South Africa.
- Scientific Capability Development, Novartis Pharma AG, Basel, Switzerland.
Zitieren
APA
Rambiritch, V., Naidoo, P., & Pillai, G. (2016). Glibenclamide population pharmacokinetic/pharmacodynamic modeling in South African type 2 diabetic subjects. Clinical Pharmacology: Advances and Applications. https://doi.org/10.2147/cpaa.s102674
Vancouver
Rambiritch V, Naidoo P, Pillai G. Glibenclamide population pharmacokinetic/pharmacodynamic modeling in South African type 2 diabetic subjects. Clinical Pharmacology: Advances and Applications. 2016. doi:10.2147/cpaa.s102674
BibTeX
@article{Rambiritch2016,
author = {Rambiritch, Virendra and Naidoo, Poobalan and Pillai, Goonaseelan},
title = {Glibenclamide population pharmacokinetic/pharmacodynamic modeling in South African type 2 diabetic subjects},
journal = {Clinical Pharmacology: Advances and Applications},
year = {2016},
doi = {10.2147/cpaa.s102674}
}
EUVIMED